Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening

Affiliations

¹ The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, New Hampshire (L.D.).
² University of Arizona College of Medicine, Phoenix, Arizona (D.B.P.).
³ Abt Associates, Cambridge, Massachusetts (M.W.).
⁴ Kaiser Permanente Research Affiliates Evidence-based Practice Center, Portland, Oregon (J.S.L.).

Comment

Louise Davies et al. Ann Intern Med. 2018.

. 2018 Nov 20;169(10):739.

doi: 10.7326/L18-0514.

¹ The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, New Hampshire (L.D.).
² University of Arizona College of Medicine, Phoenix, Arizona (D.B.P.).
³ Abt Associates, Cambridge, Massachusetts (M.W.).
⁴ Kaiser Permanente Research Affiliates Evidence-based Practice Center, Portland, Oregon (J.S.L.).

No abstract available

Comment on

Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening.
Davies L, Petitti DB, Martin L, Woo M, Lin JS. Davies L, et al. Ann Intern Med. 2018 Jul 3;169(1):36-43. doi: 10.7326/M18-0694. Epub 2018 Jun 26. Ann Intern Med. 2018. PMID: 29946705
Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening.
Rogers WA, Mintzker Y. Rogers WA, et al. Ann Intern Med. 2018 Nov 20;169(10):738-739. doi: 10.7326/L18-0513. Ann Intern Med. 2018. PMID: 30452569 No abstract available.